- Advertisement -

Reaping the promise of biotechnology – Business Mirror

IT has been nearly two decades since the Philippine government approved the sale and cultivation of genetically modified (GM) corn seeds in local farms....

Study Reveals Connection Between Aircraft Noise Pollution and Impaired Heart Function

In a significant study conducted by researchers from University College London (UCL), compelling evidence has emerged linking high levels of aircraft noise to deteriorating...

Synergistic work of cations in anion exchange membranes for OH- transport in fuel cells

Anion exchange membrane fuel cells (AEMFCs) have gained attention in the process of fuel cell development because they operate in alkaline environments, the redox...

Biotechnology Research Fellow Job; ILS Bhubaneswar Recruitment 2020, Apply Soon –...

Bhubaneswar: Institute of Life Sciences (ILS), Bhubaneswar, an autonomous institute of the Department of Biotechnology, Ministry of Science & Technology, Government of India invites applications...

Novel combination therapy may help overcome mTOR drug resistance in AML

Study led by experts at Cincinnati Children’s could lead to more effective treatment for acute myeloid leukemia, and other cancers Credit: Cincinnati Children’s

The Sector Paving the World’s Exit from COVID-19 – Switzer Financial...

As the COVID-19 pandemic causes uncertainties across economies and capital markets globally, seasoned investors and investment bankers are looking to one sector that’s proven...

Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data

Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists have revolutionized the treatment of type 2 diabetes (T2D). None of these blockbuster...

ADC Developmentfrom Concept to Clinic

Read Now Antibody-drug conjugates (ADCs) combine the specificity of monoclonal antibodies with the therapeutic activity of small molecule payloads, enabling targeted delivery...

Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data

Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists have revolutionized the treatment of type 2 diabetes (T2D). None of these blockbuster...

ADC Developmentfrom Concept to Clinic

Read Now Antibody-drug conjugates (ADCs) combine the specificity of monoclonal antibodies with the therapeutic activity of small molecule payloads, enabling targeted delivery...

Designing the Ecosystem for CGT Success

Read Now Preserving the Promise: Insights from The Cell Summit ’26 In July 2026, BioLife Solutions welcomed leaders from across the cell...

more new items

Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data

Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists have revolutionized the treatment of type 2 diabetes (T2D). None of these blockbuster...

ADC Developmentfrom Concept to Clinic

Read Now Antibody-drug conjugates (ADCs) combine the specificity of monoclonal antibodies with the therapeutic activity of small molecule payloads, enabling targeted delivery...

Designing the Ecosystem for CGT Success

Read Now Preserving the Promise: Insights from The Cell Summit ’26 In July 2026, BioLife Solutions welcomed leaders from across the cell...